Zinc Acetate Hydrate Supplementation versus Polaprezinc Supplementation for Improving Hypozincemia in Hemodialysis Patients: A Randomized Clinical Trial

Figure 3

Kaplan–Meier curves comparing the occurrence transitions of zinc dose reduction or discontinuation of oral administration between the ZAH and the PPZ groups. Adverse events occurred significantly earlier and more frequently in the ZAH group than in the PPZ group throughout the observation period ( = 0.012).